Nonetheless, prior investigations and a recent comprehensive literature review on the clinical manifestation of WS1 indicate that the pathogenic variation does not forecast the phenotype [15–18], and no common founder mutation or mutation hotspots have been found in the WFS1 gene [19]. This evidence concerns the gene WFS1 and Waardenburg syndrome type 1.